I informed the laboratories conducting research based on embryo stem cells and, in accordance with the precaution principle, the laboratories that did not reply to the survey, that, as things stood, it was no longer possible for me to invest in their companies either directly or indirectly, regardless of the investment support. I encouraged the other laboratories to continue their research in a direction that fully respected the dignity of the embryo.

In these times of crisis, when opportunities for profitable investments are not too common, on the face of it, is it reasonable to refrain from investing in companies, some of which show interesting financial potential ?
Yes, for several reasons :

  • For financial reasons : it is not profitable to invest in research on embryo stem cells, which have not produced any results.
  • For medical reasons : alternative research is already opening up encouraging prospects.
  • And for ethical reasons : regardless of the performance – of a virtual nature – of research on embryo stem cells, the end does not justify the means.

The financial and economic crisis that we are experiencing is not simply due to malfunctions in financial techniques.
The source of this crisis is also to be found in forgetting that the economy and research must serve mankind, rather than it being the other way around.

Investing in promising research that is respectful of the dignity of the embryo constitutes a precondition for establishing civilization. .